Agonist-specific voltage-dependent gating of lysosomal two-pore Na<sup>+</sup> channels.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31825310.
- Also identified by DOI 10.7554/eLife.51423 and PMC identifier 6905855.
- Licence recorded as CC0.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Mammalian two-pore-channels (TPC1, 2; <i>TPCN1, TPCN2</i>) are ubiquitously- expressed, PI(3,5)P<sub>2</sub>-activated, Na<sup>+</sup>-selective channels in the endosomes and lysosomes that regulate luminal pH homeostasis, membrane trafficking, and <i>Ebola</i> viral infection. Whereas the channel activity of TPC1 is strongly dependent on membrane voltage, TPC2 lacks such voltage dependence despite the presence of the presumed 'S4 voltage-sensing' domains. By performing high-throughput screening followed by lysosomal electrophysiology, here we identified a class of tricyclic anti-depressants (TCAs) as small-molecule agonists of TPC channels. TCAs activate both TPC1 and TPC2 in a voltage-dependent manner, referred to as <u>Ly</u>sosomal <u>Na</u><sup>+</sup> channel <u>V</u>oltage-dependent <u>A</u>ctivators (LyNa-VAs). We also identified another compound which, like PI(3,5)P<sub>2</sub>, activates TPC2 independent of voltage, suggesting the existence of agonist-specific gating mechanisms. Our identification of small-molecule TPC agonists should facilitate the studies of the cell biological roles of TPCs and can also readily explain the reported effects of TCAs in the modulation of autophagy and lysosomal functions.
Medical subject headings
- Antidepressive Agents, Tricyclic
- Calcium Channel Agonists
- Calcium Channels
- Lysosomes